Sexual Risk Behavior Associated with Transition to Injection Among Young Non-injecting Heroin Users

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2012 Oct 16

PMID 23065126

Citations 10

Authors

Mary Ellen Mackesy-Amiti

Basmattee Boodram

Chyvette Williams

Lawrence J Ouellet

Dita Broz

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to investigate the effects of transitioning from non-injection heroin use to injection drug use on sexual risk behavior. Non-injecting heroin users age 16-30 were enrolled from 2002 to 2005, and were re-interviewed at 6-month intervals for up to three years; 561 participants completed at least one follow-up interview. The majority of participants were non-Hispanic (NH) Black (54 %), 23 % were Hispanic, and 21 % were NH white. During follow-up, 154 participants (27.5 %) transitioned to injecting drugs. Logistic regression analyses were conducted using generalized estimating equations (GEE) to estimate the effect of transition to injection drug use on changes in sexual risk behavior during follow-up. Transition to injection drug use during follow-up was associated with increased likelihood of sexual risk behavior, especially for men. Harm reduction efforts that focus on preventing initiation or return to injection among non-injecting drug users may also ameliorate HIV sexual risk behaviors.

Citing Articles

Factors Associated with the Involvement of Women Drug Users in Risky Sexual Behaviors: A Narrative Review.

Sourinejad H, Noroozi M, Taleghani F, Kheirabadi G Iran J Nurs Midwifery Res. 2022; 27(5):353-362.

PMID: 36524133 PMC: 9745854. DOI: 10.4103/ijnmr.ijnmr_318_21.

Factors Associated with Sexual Risks and Risk of STIs, HIV and Other Blood-Borne Viruses Among Women Using Heroin and Other Drugs: A Systematic Literature Review.

Medina-Perucha L, Family H, Scott J, Chapman S, Dack C AIDS Behav. 2018; 23(1):222-251.

PMID: 30073636 PMC: 6342849. DOI: 10.1007/s10461-018-2238-7.

Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California.

Bluthenthal R, Wenger L, Chu D, Bourgois P, Kral A Drug Alcohol Depend. 2017; 175:210-218.

PMID: 28448905 PMC: 5494991. DOI: 10.1016/j.drugalcdep.2017.04.001.

Sociodemographic and Substance Use Disorder Determinants of HIV Sexual Risk Behavior in Men and Women in Outpatient Drug Treatment in the NIDA National Drug Abuse Treatment Clinical Trials Network.

Kidd J, Tross S, Pavlicova M, Hu M, Campbell A, Nunes E Subst Use Misuse. 2017; 52(7):858-865.

PMID: 28426361 PMC: 5710008. DOI: 10.1080/10826084.2016.1264971.

Gender, Transience, Network Partnerships and Risky Sexual Practices Among Young Persons who Inject Drugs.

Hotton A, Boodram B AIDS Behav. 2016; 21(4):982-993.

PMID: 27637498 PMC: 5344752. DOI: 10.1007/s10461-016-1555-y.

References

Fuller C, Vlahov D, Ompad D, Shah N, Arria A, Strathdee S . High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002; 66(2):189-98. DOI: 10.1016/s0376-8716(01)00200-9. View

Des Jarlais D, Paone D, Milliken J, Turner C, Miller H, Gribble J . Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999; 353(9165):1657-61. DOI: 10.1016/s0140-6736(98)07026-3. View

Evans J, Hahn J, Page-Shafer K, Lum P, Stein E, Davidson P . Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003; 80(1):137-46. PMC: 3456106. DOI: 10.1093/jurban/jtg137. View

Des Jarlais D, Arasteh K, McKnight C, Hagan H, Perlman D, Semaan S . Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health. 2011; 101(7):1277-83. PMC: 3110210. DOI: 10.2105/AJPH.2011.300130. View

Valdez A, Cepeda A, Neaigus A, Russell A . Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Int J Drug Policy. 2008; 19(6):442-9. PMC: 3008164. DOI: 10.1016/j.drugpo.2007.06.004. View

Neaigus A, Miller M, Friedman S, Hagen D, Sifaneck S, Ildefonso G . Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001; 96(6):847-60. DOI: 10.1046/j.1360-0443.2001.9668476.x. View

Kapadia F, Latka M, Wu Y, Strathdee S, Mackesy-Amiti M, Hudson S . Longitudinal determinants of consistent condom use by partner type among young injection drug users: the role of personal and partner characteristics. AIDS Behav. 2009; 15(7):1309-18. PMC: 3180628. DOI: 10.1007/s10461-009-9569-3. View

Santibanez S, Garfein R, Swartzendruber A, Purcell D, Paxton L, Greenberg A . Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006; 83(1):86-100. PMC: 2258331. DOI: 10.1007/s11524-005-9009-2. View

Turner C, Ku L, Rogers S, Lindberg L, Pleck J, Sonenstein F . Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998; 280(5365):867-73. DOI: 10.1126/science.280.5365.867. View

10.

Kral A, Bluthenthal R, Lorvick J, Gee L, Bacchetti P, Edlin B . Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001; 357(9266):1397-401. DOI: 10.1016/S0140-6736(00)04562-1. View

11.

Armstrong G, Wasley A, Simard E, McQuillan G, Kuhnert W, Alter M . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006; 144(10):705-14. DOI: 10.7326/0003-4819-144-10-200605160-00004. View

12.

Miller C, Pearce M, Moniruzzaman A, Thomas V, Christian W, Schechter M . The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people. CMAJ. 2011; 183(10):1147-54. PMC: 3134722. DOI: 10.1503/cmaj.101257. View

13.

Strathdee S, Galai N, Safaiean M, Celentano D, Vlahov D, Johnson L . Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001; 161(10):1281-8. DOI: 10.1001/archinte.161.10.1281. View

14.

Griffiths P, Gossop M, Powis B, Strang J . Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction. 1994; 89(3):301-9. DOI: 10.1111/j.1360-0443.1994.tb00896.x. View

15.

Roy E, Haley N, Leclerc P, Cedras L, Blais L, Boivin J . Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003; 80(1):92-105. PMC: 3456111. DOI: 10.1093/jurban/jtg092. View

16.

Broz D, Ouellet L . Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago. Subst Use Misuse. 2010; 45(12):2000-25. PMC: 3632501. DOI: 10.3109/10826081003682875. View

17.

Booth R, Kwiatkowski C, Chitwood D . Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000; 58(3):219-26. DOI: 10.1016/s0376-8716(99)00094-0. View

18.

Neaigus A, Gyarmathy V, Miller M, Frajzyngier V, Friedman S, Des Jarlais D . Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006; 41(4):493-503. DOI: 10.1097/01.qai.0000186391.49205.3b. View

19.

Huo D, Ouellet L . Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois. Sex Transm Dis. 2008; 36(1):35-40. PMC: 3642248. DOI: 10.1097/OLQ.0b013e318186dee3. View

20.

Neaigus A, Gyarmathy V, Miller M, Frajzyngier V, Zhao M, Friedman S . Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend. 2007; 89(2-3):234-43. PMC: 1947004. DOI: 10.1016/j.drugalcdep.2007.01.003. View